drugset / Trial / NCT07663630
A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung cancer associated cachexia.
Timeline
- Start
- 2026-07-22
- Primary completion
- 2028-02-02
- Completion
- 2029-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ponsegromab | Monoclonal antibody | 400 mg | Subcutaneous |